VEP testing and visual pathway gliomas: not quite ready for prime time.
Siatkowski
R Michael
RM
D003362:Cost-Benefit Analysis; D003941:Diagnostic Techniques, Ophthalmological; D005074:Evoked Potentials, Visual; D006801:Humans; D020339:Optic Nerve Glioma / Q000175:diagnosis* / Q000503:physiopathology; D019574:Optic Nerve Neoplasms / Q000175:diagnosis* / Q000503:physiopathology*; D016896:Treatment Outcome; D014795:Visual Pathways / Q000473:pathology* / Q000503:physiopathology